ReP USP - Resultado da busca

Artigo de periodico
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series (2018)
Pallo, Pablo Arturo Olivo; Souza, Fernando Henrique Carlos De; Miossi, Renata; Shinjo, Samuel Katsuyuki
Source: Advances in rheumatology. Unidade: FM
Subjects: MIOSITE, FÁRMACOS IMUNOSSUPRESSORES, DOENÇAS BACTERIANAS SEXUALMENTE TRANSMISSÍVEIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALLO, Pablo Arturo Olivo et al. Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series. Advances in rheumatology, v. 58, 2018Tradução . . Disponível em: https://doi.org/10.1186/s42358-018-0035-7. Acesso em: 01 nov. 2024.
APA
Pallo, P. A. O., Souza, F. H. C. D., Miossi, R., & Shinjo, S. K. (2018). Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series. Advances in rheumatology, 58. doi:10.1186/s42358-018-0035-7
NLM
Pallo PAO, Souza FHCD, Miossi R, Shinjo SK. Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s42358-018-0035-7
Vancouver
Pallo PAO, Souza FHCD, Miossi R, Shinjo SK. Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s42358-018-0035-7
Artigo de periodico
Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity (2017)
Souza, R. C. de; Souza, F. H. C. de; Miossi, R.; Shinjo, Sueli Mieko Oba
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: MIOSITE, FÁRMACOS IMUNOSSUPRESSORES, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, R. C. de et al. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, v. 35, n. 6, p. 1011-1013, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/25488. Acesso em: 01 nov. 2024.
APA
Souza, R. C. de, Souza, F. H. C. de, Miossi, R., & Shinjo, S. M. O. (2017). Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, 35( 6), 1011-1013. Recuperado de http://observatorio.fm.usp.br/handle/OPI/25488
NLM
Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2024 nov. 01 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488
Vancouver
Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2024 nov. 01 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488
Trabalho de evento-resumo periodico
Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies (2015)
Souza, Fernando Henrique Carlos de; Miossi, Renata; Moraes, Julio C. B.; Bonfiglioli, Karina; Bonfá, Eloisa; Shinjo, Samuel Katsuyuki
Conference titles: ACR/ARHP Annual Meeting. Unidade: FM
Subjects: INFLAMAÇÃO, AUTOANTICORPOS, MIOSITE, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Fernando Henrique Carlos de et al. Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies. . Atlanta: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf. Acesso em: 01 nov. 2024. , 2015
APA
Souza, F. H. C. de, Miossi, R., Moraes, J. C. B., Bonfiglioli, K., Bonfá, E., & Shinjo, S. K. (2015). Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies. Atlanta: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/art.39448
NLM
Souza FHC de, Miossi R, Moraes JCB, Bonfiglioli K, Bonfá E, Shinjo SK. Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies [Internet]. 2015 ; 67( S10):[citado 2024 nov. 01 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf
Vancouver
Souza FHC de, Miossi R, Moraes JCB, Bonfiglioli K, Bonfá E, Shinjo SK. Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies [Internet]. 2015 ; 67( S10):[citado 2024 nov. 01 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39448/pdf

USP Schools

ReP

Filtros

Authors

Subjects